ATE345820T1 - Diagnostisches mittel für die exokrine pankreasfunktion - Google Patents

Diagnostisches mittel für die exokrine pankreasfunktion

Info

Publication number
ATE345820T1
ATE345820T1 AT02700697T AT02700697T ATE345820T1 AT E345820 T1 ATE345820 T1 AT E345820T1 AT 02700697 T AT02700697 T AT 02700697T AT 02700697 T AT02700697 T AT 02700697T AT E345820 T1 ATE345820 T1 AT E345820T1
Authority
AT
Austria
Prior art keywords
exocrine pancreatic
pancreatic function
protecting group
diagnostic
agency
Prior art date
Application number
AT02700697T
Other languages
English (en)
Inventor
Tadashi Kohno
Isaburo Hosoi
Asuka Ito
Junko Hirayama
Kenji Maeda
Original Assignee
Tokyo Gas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Gas Co Ltd filed Critical Tokyo Gas Co Ltd
Application granted granted Critical
Publication of ATE345820T1 publication Critical patent/ATE345820T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02700697T 2001-08-10 2002-02-22 Diagnostisches mittel für die exokrine pankreasfunktion ATE345820T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001243142 2001-08-10

Publications (1)

Publication Number Publication Date
ATE345820T1 true ATE345820T1 (de) 2006-12-15

Family

ID=19073284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700697T ATE345820T1 (de) 2001-08-10 2002-02-22 Diagnostisches mittel für die exokrine pankreasfunktion

Country Status (13)

Country Link
US (2) US7208525B2 (de)
EP (1) EP1424083B1 (de)
AT (1) ATE345820T1 (de)
CA (1) CA2453278C (de)
CY (1) CY1105802T1 (de)
DE (1) DE60216293T2 (de)
DK (1) DK1424083T3 (de)
ES (1) ES2276908T3 (de)
MX (1) MXPA04001260A (de)
NO (1) NO331184B1 (de)
NZ (1) NZ530072A (de)
PT (1) PT1424083E (de)
WO (1) WO2003015832A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080011599A1 (en) 2006-07-12 2008-01-17 Brabender Dennis M Sputtering apparatus including novel target mounting and/or control
EP3541762B1 (de) 2016-11-17 2022-03-02 Cardinal CG Company Statisch-dissipative beschichtungstechnologie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3340699B2 (ja) * 1998-06-05 2002-11-05 東京瓦斯株式会社 膵外分泌機能診断剤
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤

Also Published As

Publication number Publication date
MXPA04001260A (es) 2004-05-27
EP1424083A4 (de) 2004-11-03
NZ530072A (en) 2005-05-27
NO331184B1 (no) 2011-10-24
EP1424083A1 (de) 2004-06-02
CA2453278C (en) 2011-01-25
CA2453278A1 (en) 2003-02-27
US20050147557A1 (en) 2005-07-07
CY1105802T1 (el) 2011-02-02
DE60216293T2 (de) 2007-06-21
NO20040571L (no) 2004-03-23
DK1424083T3 (da) 2006-12-18
DE60216293D1 (de) 2007-01-04
EP1424083B1 (de) 2006-11-22
ES2276908T3 (es) 2007-07-01
US7208525B2 (en) 2007-04-24
US7662857B2 (en) 2010-02-16
WO2003015832A1 (en) 2003-02-27
US20070154394A1 (en) 2007-07-05
PT1424083E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
EP1006122A4 (de) Phenylethylenamin-derivate
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
EP1477482A4 (de) Neues phenylalaninderivat
ATE241998T1 (de) Multikatalytische protease-inhibitoren
DK1073432T3 (da) Anvendelse af D serin eller D alanin til behandling af skizofreni
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
BRPI0610312B8 (pt) dispositivo de assistência à caminhada
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
DE50204780D1 (de) Arylsulfonamide als antivirale mittel
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
DK1154986T3 (da) Fremgangsmåde til fremstilling af iopamidol
BR0011728A (pt) Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide
WO2005042590A3 (fr) Derives amphiphiles de cyclodextrines, leur procede de preparation et leurs utilisations
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
ATE345820T1 (de) Diagnostisches mittel für die exokrine pankreasfunktion
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
NO994135L (no) Kinoksalindioner
BR0007499A (pt) Composto
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
BRPI0417423A (pt) processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
MXPA05006931A (es) Analogos de 1-desamino-8-d-arginina vasopresina.
EP1574521A4 (de) Verfahren zum schützen vonprotein-thiolgruppen
BR0108622A (pt) Processo para a n-formilação seletiva de n-hidroxil aminas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1424083

Country of ref document: EP